Tiger Brokers

Abbott Laboratories Stock Rises 10.7%, Outperforms Peers

Dow Jones
Jul 17

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Abbott Laboratories jumped 10.7% to $98.83 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.5% to 7,533.77 and Dow Jones Industrial Average falling 0.2% to 52,552.97.

This was the stock's second consecutive day of gains.

Abbott Laboratories closed 28.1% below its 52-week high of $137.49, which the company achieved on September 22nd.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.2% to $249.97, Pfizer Inc. rose 1.3% to $25.14, and Merck & Co. Inc. rose 3.25% to $127.63.

Trading volume totaled 31.2 million, compared to the 50-day average of 13.0 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 16, 2026 16:32 ET (20:32 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10